vs

Side-by-side financial comparison of BRINKS CO (BCO) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

BRINKS CO is the larger business by last-quarter revenue ($1.4B vs $719.4M, roughly 1.9× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 4.9%, a 68.2% gap on every dollar of revenue. On growth, BRINKS CO posted the faster year-over-year revenue change (9.1% vs 3.1%). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 5.6%).

The Brink's Company is an American cash handling company, headquartered in Richmond, Virginia. Its operations include cash-in-transit, ATM replenishment & maintenance, and cash management & payment services, such as vault outsourcing, money processing, intelligent safe services, and international transportation of valuables.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

BCO vs DOC — Head-to-Head

Bigger by revenue
BCO
BCO
1.9× larger
BCO
$1.4B
$719.4M
DOC
Growing faster (revenue YoY)
BCO
BCO
+6.0% gap
BCO
9.1%
3.1%
DOC
Higher net margin
DOC
DOC
68.2% more per $
DOC
73.2%
4.9%
BCO
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
5.6%
BCO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCO
BCO
DOC
DOC
Revenue
$1.4B
$719.4M
Net Profit
$68.1M
$114.0M
Gross Margin
27.7%
Operating Margin
13.1%
17.4%
Net Margin
4.9%
73.2%
Revenue YoY
9.1%
3.1%
Net Profit YoY
76.9%
2406.4%
EPS (diluted)
$1.62
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCO
BCO
DOC
DOC
Q4 25
$1.4B
$719.4M
Q3 25
$1.3B
$705.9M
Q2 25
$1.3B
$694.3M
Q1 25
$1.2B
$702.9M
Q4 24
$1.3B
$698.0M
Q3 24
$1.3B
$700.4M
Q2 24
$1.3B
$695.5M
Q1 24
$1.2B
$606.6M
Net Profit
BCO
BCO
DOC
DOC
Q4 25
$68.1M
$114.0M
Q3 25
$36.3M
$-117.1M
Q2 25
$43.7M
$31.7M
Q1 25
$51.6M
$42.8M
Q4 24
$38.5M
$4.5M
Q3 24
$28.9M
$85.9M
Q2 24
$46.2M
$146.0M
Q1 24
$49.3M
$6.7M
Gross Margin
BCO
BCO
DOC
DOC
Q4 25
27.7%
Q3 25
25.8%
58.6%
Q2 25
24.9%
60.2%
Q1 25
24.6%
61.1%
Q4 24
26.1%
60.3%
Q3 24
25.0%
60.0%
Q2 24
25.2%
60.6%
Q1 24
25.0%
59.8%
Operating Margin
BCO
BCO
DOC
DOC
Q4 25
13.1%
17.4%
Q3 25
11.4%
9.2%
Q2 25
10.3%
5.7%
Q1 25
9.6%
7.7%
Q4 24
8.3%
-2.2%
Q3 24
8.9%
14.1%
Q2 24
9.3%
22.3%
Q1 24
9.8%
3.7%
Net Margin
BCO
BCO
DOC
DOC
Q4 25
4.9%
73.2%
Q3 25
2.7%
-16.6%
Q2 25
3.4%
4.6%
Q1 25
4.1%
6.1%
Q4 24
3.0%
0.7%
Q3 24
2.3%
12.3%
Q2 24
3.7%
21.0%
Q1 24
4.0%
1.1%
EPS (diluted)
BCO
BCO
DOC
DOC
Q4 25
$1.62
$0.16
Q3 25
$0.86
$-0.17
Q2 25
$1.03
$0.05
Q1 25
$1.18
$0.06
Q4 24
$0.87
$0.02
Q3 24
$0.65
$0.12
Q2 24
$1.02
$0.21
Q1 24
$1.09
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCO
BCO
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$1.7B
$467.5M
Total DebtLower is stronger
$4.0B
$9.8B
Stockholders' EquityBook value
$277.7M
$7.5B
Total Assets
$7.3B
$20.3B
Debt / EquityLower = less leverage
14.31×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCO
BCO
DOC
DOC
Q4 25
$1.7B
$467.5M
Q3 25
$1.3B
$91.0M
Q2 25
$1.4B
$89.4M
Q1 25
$1.2B
$70.6M
Q4 24
$1.4B
$119.8M
Q3 24
$1.2B
$180.4M
Q2 24
$1.2B
$106.9M
Q1 24
$1.1B
$101.8M
Total Debt
BCO
BCO
DOC
DOC
Q4 25
$4.0B
$9.8B
Q3 25
$3.8B
$9.1B
Q2 25
$3.9B
$9.0B
Q1 25
$3.7B
$8.9B
Q4 24
$3.7B
$8.7B
Q3 24
$3.7B
$8.6B
Q2 24
$3.6B
$8.6B
Q1 24
$3.4B
$8.8B
Stockholders' Equity
BCO
BCO
DOC
DOC
Q4 25
$277.7M
$7.5B
Q3 25
$268.5M
$7.6B
Q2 25
$254.6M
$7.9B
Q1 25
$205.8M
$8.2B
Q4 24
$184.9M
$8.4B
Q3 24
$277.1M
$8.6B
Q2 24
$320.5M
$8.8B
Q1 24
$396.4M
$8.9B
Total Assets
BCO
BCO
DOC
DOC
Q4 25
$7.3B
$20.3B
Q3 25
$7.0B
$19.6B
Q2 25
$7.1B
$19.8B
Q1 25
$6.6B
$19.8B
Q4 24
$6.6B
$19.9B
Q3 24
$6.7B
$20.0B
Q2 24
$6.6B
$20.2B
Q1 24
$6.7B
$20.5B
Debt / Equity
BCO
BCO
DOC
DOC
Q4 25
14.31×
1.31×
Q3 25
14.05×
1.20×
Q2 25
15.48×
1.14×
Q1 25
18.19×
1.08×
Q4 24
20.26×
1.04×
Q3 24
13.39×
1.00×
Q2 24
11.26×
0.98×
Q1 24
8.67×
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCO
BCO
DOC
DOC
Operating Cash FlowLast quarter
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
3.5%
124.4%
Cash ConversionOCF / Net Profit
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCO
BCO
DOC
DOC
Q4 25
$1.3B
Q3 25
$122.1M
$315.0M
Q2 25
$363.5M
Q1 25
$-60.2M
$279.4M
Q4 24
$369.8M
$1.1B
Q3 24
$58.4M
$318.2M
Q2 24
$-66.1M
$316.2M
Q1 24
$63.9M
$152.6M
Free Cash Flow
BCO
BCO
DOC
DOC
Q4 25
$357.0M
Q3 25
$77.4M
Q2 25
Q1 25
$-119.1M
Q4 24
$307.2M
$333.7M
Q3 24
$7.4M
Q2 24
$-122.8M
Q1 24
$11.7M
FCF Margin
BCO
BCO
DOC
DOC
Q4 25
49.6%
Q3 25
5.8%
Q2 25
Q1 25
-9.6%
Q4 24
24.3%
47.8%
Q3 24
0.6%
Q2 24
-9.8%
Q1 24
0.9%
Capex Intensity
BCO
BCO
DOC
DOC
Q4 25
3.5%
124.4%
Q3 25
3.3%
Q2 25
4.0%
Q1 25
4.7%
Q4 24
5.0%
105.6%
Q3 24
4.1%
Q2 24
4.5%
Q1 24
4.2%
Cash Conversion
BCO
BCO
DOC
DOC
Q4 25
10.99×
Q3 25
3.36×
Q2 25
11.48×
Q1 25
-1.17×
6.52×
Q4 24
9.61×
235.43×
Q3 24
2.02×
3.71×
Q2 24
-1.43×
2.17×
Q1 24
1.30×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons